Over the past 12 months, 7 insiders at Solid Biosciences Inc. filed 29 open-market SEC Form 4 transactions on SLDB: 0 purchases worth $0 and 29 sales worth $2.7M. Insiders have been net sellers over this period. The most recent filing was on Feb 18, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 18, 26 | Gabriel BrooksChief Medical Officer | SELL | 0 | $5.82 | $0 |
| Feb 18, 26 | Alexander CumboPresident and CEO | SELL | 16.6K | $5.82 | $97K |
| Feb 18, 26 | Ilan GanotDirector | SELL | 2.7K | $5.82 | $15K |
| Feb 18, 26 | Jessie HanrahanChief Regulatory Officer | SELL | 4.1K | $5.82 | $24K |
| Feb 18, 26 | Paul HerzichChief Technology Officer | SELL | 3.6K | $5.82 | $21K |
| Feb 18, 26 | David T HowtonChief Operating Officer | SELL | 7.5K | $5.82 | $43K |
| Feb 18, 26 | Kevin TanCFO & Treasurer | SELL | 5.4K | $5.82 | $31K |
| Feb 4, 26 | Gabriel BrooksChief Medical Officer | SELL | 12.6K | $6.44 | $81K |
| Feb 4, 26 | Alexander CumboPresident and CEO | SELL | 48.9K | $6.44 | $315K |
| Feb 4, 26 | Ilan GanotDirector | SELL | 7.2K | $6.44 | $46K |
| Feb 4, 26 | Jessie HanrahanChief Regulatory Officer | SELL | 12.3K | $6.44 | $80K |
| Feb 4, 26 | Paul HerzichChief Technology Officer | SELL | 10.9K | $6.44 | $70K |
| Feb 4, 26 | David T HowtonChief Operating Officer | SELL | 18.9K | $6.44 | $122K |
| Feb 4, 26 | Kevin TanCFO & Treasurer | SELL | 14.8K | $6.44 | $95K |
| Feb 2, 26 | Gabriel BrooksChief Medical Officer | SELL | 28.3K | $6.44 | $182K |
| Feb 2, 26 | Alexander CumboPresident and CEO | SELL | 80.3K | $6.44 | $517K |
| Feb 2, 26 | Jessie HanrahanChief Regulatory Officer | SELL | 26.5K | $6.44 | $171K |
| Feb 2, 26 | Paul HerzichChief Technology Officer | SELL | 26.3K | $6.44 | $169K |
| Feb 2, 26 | David T HowtonChief Operating Officer | SELL | 37.8K | $6.44 | $243K |
| Feb 2, 26 | Kevin TanCFO & Treasurer | SELL | 26.8K | $6.44 | $173K |
| Jan 28, 26 | Ilan GanotDirector | SELL | 191 | $6.59 | $1K |
| Jan 13, 26 | Kevin TanCFO & Treasurer | SELL | 5.7K | $5.27 | $30K |
| Jan 5, 26 | Ilan GanotDirector | SELL | 1.1K | $5.43 | $6K |
| Dec 3, 25 | Alexander CumboPresident and CEO | SELL | 10.8K | $5.11 | $55K |
| Dec 3, 25 | Jessie HanrahanChief Regulatory Officer | SELL | 4.5K | $5.11 | $23K |
| Dec 3, 25 | Paul HerzichChief Technology Officer | SELL | 2.7K | $5.11 | $14K |
| Dec 3, 25 | David T HowtonChief Operating Officer | SELL | 4.9K | $5.11 | $25K |
| Nov 10, 25 | Ilan GanotDirector | SELL | 3.3K | $4.12 | $14K |
| Oct 20, 25 | Gabriel BrooksChief Medical Officer | SELL | 2.9K | $5.96 | $17K |
| Mar 11, 25 | Clare KahnDirector | BUY | 1.9K | $5.34 | $10K |
| Feb 19, 25 | Bcls Sb Investco, LpTenPercentOwner | BUY | 1.00M | $4.03 | $4.0M |
| Feb 19, 25 | Joseph EdelmanDirector,TenPercentOwner | BUY | 5.00M | $4.03 | $20.1M |
| Feb 18, 25 | Robert AtchinsonTenPercentOwner | BUY | 252.5K | $7.56 | $1.9M |
| Feb 14, 25 | Gabriel BrooksChief Medical Officer | SELL | 3.3K | $3.96 | $13K |
| Feb 14, 25 | Alexander CumboPresident and CEO | SELL | 11.4K | $3.96 | $45K |
| Feb 14, 25 | Ilan GanotDirector | SELL | 1.7K | $3.96 | $7K |
| Feb 14, 25 | Jessie HanrahanChief Regulatory Officer | SELL | 3.1K | $3.96 | $12K |
| Feb 14, 25 | Paul HerzichChief Technology Officer | SELL | 2.7K | $3.96 | $11K |
| Feb 14, 25 | David T HowtonChief Operating Officer | SELL | 5.6K | $3.96 | $22K |
| Feb 14, 25 | Kevin TanCFO & Treasurer | SELL | 3.2K | $3.96 | $13K |
| Jan 28, 25 | Ilan GanotDirector | SELL | 144 | $3.11 | $448 |
| Jan 10, 25 | Kevin TanCFO & Treasurer | SELL | 4.1K | $3.89 | $16K |
| Jan 6, 25 | Ilan GanotDirector | SELL | 1.1K | $4.31 | $5K |
| Dec 3, 24 | Alexander CumboPresident and CEO | SELL | 11.1K | $5.60 | $62K |
| Dec 3, 24 | Jessie HanrahanChief Regulatory Officer | SELL | 4.6K | $5.60 | $26K |
| Dec 3, 24 | Paul HerzichChief Technology Officer | SELL | 2.8K | $5.60 | $16K |
| Dec 3, 24 | David T HowtonChief Operating Officer | SELL | 5.1K | $5.60 | $28K |
| Oct 21, 24 | Gabriel BrooksChief Medical Officer | SELL | 2.9K | $6.50 | $19K |
| Jun 7, 24 | Clare KahnDirector | BUY | 1.1K | $7.67 | $8K |
| May 2, 24 | Ilan GanotDirector | SELL | 462 | $10.33 | $5K |
Over the past 12 months, insiders at Solid Biosciences Inc. filed 0 open-market purchases worth $0 and 29 sales worth $2.7M on SLDB, which makes them net sellers over the period. The most recent Form 4 was filed on Feb 18, 26.
The largest recent open-market SLDB insider purchase in our data was $20.1M by Joseph Edelman, Director,TenPercentOwner, filed on Feb 19, 25.
7 different insiders at Solid Biosciences Inc. filed open-market SEC Form 4 transactions on SLDB over the last 12 months.
InsiderTape plots every SLDB insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Solid Biosciences Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →